Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Information provided to patients (pts) with neuroendocrine tumors (NETs) about burden and treatment proposed may influence pts’ adherence to treatment, outpatient monitoring and quality of life (QoL), but can also cause anxiety.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Hautefeuille V
Authors: Hautefeuille V, Do Cao C, Coriat R, Dominguez S, Mineur L,
Keywords: Patients’ perception of information, Quality of Life, Lanreotide,
Introduction: OPALINE Study focuses on patients with pNET. 2 targeted therapies (TT) offer new options to treat these patients: mTORi (everolimus) and a multi-targeted inhibitor (sunitinib).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Lombard-Bohas C, Lepage C, Vicaut E, Dominguez S, Coriat R,
Keywords: pNET, targeted therapies,
Introduction: OPALINE Study focuses on patients with pNET. Two targeted therapies (TT) offer new options to treat these patients: mTORi (everolimus) and a multi-targeted inhibitor (sunitinib).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Lombard-Bohas V
Authors: Lombard-Bohas C, Lepage C, Vicaut E, Dominguez S, Coriat R,
Keywords: pNET, targeted therapy,
Introduction: Platin-etoposide (PE), the gold standard regimen for poorly differentiated neuroendocrine carcinomas, might be effective in well-differentiated pancreatic neuroendocrine tumors (WD-PNETs) with a high Ki-67 proliferation index.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: BAUDIN E
Authors: Roquin G, Baudin E, Lombard-Bohas C, Cadiot G, Dominguez S,
Keywords: platin/etoposide, pNETs, Ki-67,